Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1, and the lapse-in-funding notice has been removed. The study information on the page remains unchanged.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice about potential delays and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe updates include lightweight metadata/text changes such as a new glossary display option, capitalization of labels (e.g., QC criteria), and a new revision footer label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded North Carolina under the new Locations section. Removed the HHS Vulnerability Disclosure item from the footer; page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.